UA94980C2 - лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты) - Google Patents

лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты)

Info

Publication number
UA94980C2
UA94980C2 UAA200907425A UAA200907425A UA94980C2 UA 94980 C2 UA94980 C2 UA 94980C2 UA A200907425 A UAA200907425 A UA A200907425A UA A200907425 A UAA200907425 A UA A200907425A UA 94980 C2 UA94980 C2 UA 94980C2
Authority
UA
Ukraine
Prior art keywords
variants
processes
preparation
cardiovascular drug
prolonged action
Prior art date
Application number
UAA200907425A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марк Вольфович Штейнгарт
Роман Николаевич Приходько
Original Assignee
Роман Николаевич Приходько
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Роман Николаевич Приходько filed Critical Роман Николаевич Приходько
Priority to UAA200907425A priority Critical patent/UA94980C2/ru
Priority to PCT/UA2010/000026 priority patent/WO2011008183A1/ru
Publication of UA94980C2 publication Critical patent/UA94980C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине и химико-фармацевтической промышленности, в частности, к созданию, производству и применению препарата сердечнососудистого действия - триметазидина дигидрохлорида в форме матриксных таблеток с регулируемым высвобождением лекарственного вещества в течение 12 и 24 часов.
UAA200907425A 2009-07-15 2009-07-15 лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты) UA94980C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA200907425A UA94980C2 (ru) 2009-07-15 2009-07-15 лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты)
PCT/UA2010/000026 WO2011008183A1 (ru) 2009-07-15 2010-05-14 Лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с пролонгированным действием (варианты) и способы его получения (варианты)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200907425A UA94980C2 (ru) 2009-07-15 2009-07-15 лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты)

Publications (1)

Publication Number Publication Date
UA94980C2 true UA94980C2 (ru) 2011-06-25

Family

ID=43449604

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907425A UA94980C2 (ru) 2009-07-15 2009-07-15 лекарственное средство триметазидина дигидрохлорида в форме матриксной таблетки с прологированным действием (варианты) и способы его получения (варианты)

Country Status (2)

Country Link
UA (1) UA94980C2 (ru)
WO (1) WO2011008183A1 (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1195160E (pt) * 2000-10-05 2009-12-07 Usv Ltd Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
UA12297U (en) * 2005-11-24 2006-01-16 Pharma Start Ltd Liability Com Matrix tablet providing for delayed release of trimetasin
RU2362548C1 (ru) * 2007-11-20 2009-07-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения

Also Published As

Publication number Publication date
WO2011008183A1 (ru) 2011-01-20

Similar Documents

Publication Publication Date Title
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
TW201711676A (en) Ferric citrate dosage forms
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
IL208832A (en) 3-Aminocarbazole Compound, Pharmaceutical Preparations Containing Them, Methods of Preparation and Use for Drug Preparation
WO2009068214A3 (de) Heteroaryl-substituierte piperidine
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
MX343358B (es) Tabletas de acetato de ulipristal.
IL218370A0 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen, processes for producing the same and uses thereof
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
WO2011104652A3 (en) Veterinary compositions
IN2012DN02793A (ru)
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
MX2010002506A (es) Compuestos de nicotinamida sustituidos y uso de estos en medicamentos.
MX2014012164A (es) Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica.
IL213671A (en) Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines
MX2014012799A (es) Tabletas recubiertas y la produccion de las mismas.
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX2012002631A (es) Capsulas con aroma.
PH12014502221A1 (en) Prasugrel-containing immediate release stable oral pharmaceutical compositions
MY166555A (en) Substituted piperidine
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
IL213105A (en) Compounds, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
MX2012001893A (es) Tableteado de eritritol e isomaltosa.
GB0615105D0 (en) Novel compounds